Hip protectors in the elderly: lack of effectiveness or just suboptimal implementation?
European Review of Aging and Physical Activity volume 3, pages 85–90 (2006)
Hip protectors seemed to be the only non-pharmacological intervention to effectively prevent hip fractures in high-risk populations. In contrast, recently published trials did not find hip fracture reduction through hip protector interventions. An updated Cochrane review concluded that the device is ineffective for community-dwelling elderly and of uncertain effectiveness for institutionalised elderly. However, some primary studies used suboptimal implementation of hip protectors, which has led to low adherence and ineffectiveness of the intervention. Shortcomings in implementation techniques have not been assessed by the Cochrane review. Therefore, reviewers should explicitly assess whether the intervention was well planned and competently administered. As a checklist cannot adequately assess individual, study-specific implementation flaws, we suggest narrative expert review and feedback to the authors of the primary study.
Hip fractures are a major cause of disability and functional impairment among the elderly . Most cases result from fall-related direct impact on the greater trochanter of the proximal femur [20, 27]. Fall prevention programmes have been extensively studied. Multifaceted interventions may prevent falls. There is no evidence that fall prevention programmes reduce hip fractures . National guidelines recommend offering hip protectors to all nursing home residents . Hip protectors have been suggested to be the only non-pharmacological intervention to effectively prevent hip fractures in high-risk populations [10, 14, 16]. However, recently published trials did not demonstrate hip fracture reduction through hip protector intervention [18, 24]. An updated Cochrane review concluded that hip protectors are ineffective for community-dwelling elderly and their effectiveness remains uncertain for institutionalised elderly . However, the effectiveness of a hip protector intervention depends on the baseline risk of the population and the adherence to wear the device. Hip protectors do not work unless they are worn at the time of the fall. Suboptimal implementation of hip protectors might lead to low adherence and, therefore, to ineffectiveness of the intervention. We aim to illustrate that quality assessment even within high-quality systematic reviews does not reflect if the intervention programmes were well planned and competently administered.
Materials and methods
We searched PubMed (to April 2006) to find systematic reviews on hip protectors. Reference lists of the retrieved two meta-analyses were reviewed to identify primary studies. We present a brief overview of the external evidence on hip protectors summarised in the Cochrane review  and briefly discuss disagreement with the review by Sawka et al. . We analysed shortcomings in implementation techniques, which cannot be identified by the usual approach of critically appraising randomised controlled trials. Therefore, we exemplarily focused on two primary studies that the Cochrane reviewers rated as having very good methodological quality. Both studies [18, 24] received the largest weight in the meta-analysis of institutional setting studies and had a major impact on the interpretation of the effectiveness of hip protector interventions.
How hip protectors work
Hip protectors are devices designed to protect the hipbones during a fall. Different protectors have been studied in several randomised controlled trials in various countries . Most types consist of plastic shields or foam pads that are held in place at the hips with specially designed underwear. Energy shunting (hard-shelled) hip protectors are made of durable plastic, designed to divert a direct impact away from the greater trochanter onto the surrounding soft tissue. Soft hip pads primarily absorb energy. Biomechanical studies suggest that the force-attenuating capacity of the hard-shelled hip protectors is superior to soft, energy-absorbing ones [11, 22, 25]. Only few hip fractures have been reported with documented use of the hip protector [16, 18, 24]. However, verification if the hip protector was correctly used at the time of fall is difficult .
External evidence on the effectiveness of hip protectors
The first randomised controlled trial investigating the effectiveness of hip protectors in nursing home residents was published 13 years ago , followed by several trials and reviews on hip protector intervention programmes.
Recently, the sixth update of the Cochrane review was published . Figures 1 and 2 show the results of this meta-analysis. The authors have pooled five trials that used individual randomisation together with six cluster randomised trials. The studies were carried out in nursing homes or residential homes. The results show a significant reduction in hip fracture incidence [relative risk (RR) 0.77, 95% confidence interval (CI) 0.62 to 0.97]. However, the upper limit of the confidence interval indicates marginal statistical significance. Sensitivity analyses were carried out because of statistical heterogeneity within the group of cluster randomised trials. Removal of the trial by Kannus et al.  results in loss of significant effectiveness of hip protector interventions, whereas the significant effect remains while removing the trial by O’Halloran . Data pooling of three individually randomised trials of hip protector interventions in community-dwelling elderly resulted in no reduction of hip fracture incidence (RR 1.16, 95% CI 0.85 to 1.59).
Discordance among systematic reviews on hip protectors
Sawka et al.  suggested a more pronounced relative risk reduction in nursing home residents allocated to hip protector intervention (RR 0.50, 95% CI 0.28–0.91). Assessment of study quality was a source of discordance among the two meta-analyses. Inclusion criteria were stricter in the review by Sawka et al. Five trials considered in the Cochrane review were excluded due to violation of randomisation [10, 14], lack of complete random allocation [2, 8] and unit of analysis bias [3, 10, 14]. Although the trial by O’Halloran et al.  has been published after finishing literature search for the review by Sawka et al., the authors stated that the trial would not have met their strict inclusion criteria due to major methodological shortcomings.
Sawka et al. classified the population investigated by van Schoor et al.  as community dwelling, whereas the Cochrane review defined it as institutionalised. As half of the study population consisted of elderly living in apartment houses or homes for the elderly and half of nursing home residents, both classifications have shortcomings. This problem is typical for meta-analyses that use aggregate, instead of individual, patient data. The latter one is judged to be the more valid method to summarise the results of multiple studies . It has been suggested that meta-analyses based on aggregate patient data should be viewed as only exploratory, as they do not provide reliable information .
Diversity of hip protector interventions
The Cochrane review  as well as the review by Sawka et al.  quantitatively summarised studies regardless of different co-interventions or different control group interventions. Most studies investigated the effects of a single provision of protectors; other intervention programmes comprised both education and information approaches and provision of hip protectors . The latter were more or less complex interventions, which consist of components that depend on each other and, therefore, cannot be separated . All trials except one used no intervention as comparator. This one trial  offered optimised usual care to the control group through information to nurses about hip protectors and provision of protectors for demonstration purposes. In both systematic reviews, trials were synthesised through meta-analysis without exploring and considering clinical heterogeneity. Unlike statistical heterogeneity, clinical heterogeneity due to different inclusion criteria, manner of administration of interventions or measurement of outcome parameters can be identified before data analysis. Suggestions have been made on how to consider clinical heterogeneity in systematic reviews .
Clinical flaws despite high-quality rating of methodology
The Cochrane review  applied rigorous quality criteria well-known to influence the validity of randomised controlled trials : allocation concealment, clear definition of inclusion and exclusion criteria, loss to follow-up, comparability of study groups, equal treatment of study groups, except of the intervention, and intention-to-treat analysis. Further criteria specially addressing hip protector trial methodology were applied: active or scheduled follow-up ascertainment and monitoring of adherence. However, appraising trials using formal checklists may overlook important clinical flaws in the original trials . This can be illustrated exemplarily by critical appraisal of two included trials [18, 24]. The trials by van Schoor et al.  and O’Halloran et al.  were chosen, as they received the largest weight in the data pooling of institutional setting studies (Fig. 1).
Van Schoor et al.  investigated the effectiveness of a hip protector intervention programme in a heterogeneous population of elderly living in apartment houses, residential homes and nursing homes. The intervention did not result in a reduction of hip fractures, and the authors claimed the ineffectiveness of the hip protector.
However, the study has several important methodological shortcomings. The power calculation was based on a one-sided p value and a reduction of hip fractures of 75%. Such a pronounced effect has never been shown before. Sample-size calculation indicated the need of 700 participants. However, only 561 participants were enrolled. During the trial, follow-up was extended to 69.6 weeks to increase the number of events.
The education approach used in the intervention group was scarcely described. The underlying education theory was not mentioned. Precise details of the interventions intended for each group and how these were actually administered were not given. The implementation of the intervention may be less than optimal for the group of cognitively impaired persons because there was no structured involvement of caregivers.
Van Schoor et al. emphasized single randomisation as an important methodological strength of their study. However, the avoidance of cluster randomisation seems to be problematic in this setting. Contamination could have compromised the study, as the same caregivers looked after participants of both study groups.
Outcome assessment relied on participant-kept calendar. As baseline data indicated cognitive impairment in approximately 75% of participants, the reliability of the data is of major concern. None of these obvious shortcomings has been reflected in the Cochrane review, which classified the trial of high methodological quality with a score of 10 out of a possible 10.
The study by O’Halloran  is by far the largest trial investigating a hip protector intervention in institutionalised elderly. Thus, it received a weight of 46% in the meta-analysis of the Cochrane review. The sample consisted of 127 nursing and residential homes with 4,117 beds in Northern Ireland. The combined intervention of provision of hip protectors, education and information did not result in a reduction of hip fractures during 72 weeks of follow-up. However, this study also has important methodological shortcomings, which might have heavily affected the results. A mixed population was investigated, including nursing home residents and non-nursing home residents. Baseline data of participants are not reported. It remains unclear whether the two study groups were comparable at the beginning of the study. A flow of participants through the trial, which discloses the number of subjects with early study termination and the proportion of subjects that have been included after randomisation, is not given. The absolute number of participating residents remains unknown, as data are reported as events per 100 occupied beds or per 100 residents per year.
The multifaceted intervention consisted of an education session for home staff, distribution of manufacturer’s information material, provision of a videotape on hip protectors, information for residents and relatives on request, counselling by a nurse facilitator and provision of hip protectors for every resident agreeing to wear them. No details are reported on how the education and information programme was structured, whether it was based on an education theory and if so, whether it had been sufficiently explored before application. The reader cannot assess if an appropriate intervention was administered. Access to the education programme is not possible neither by further references nor authors’ offer to contact them.
It remains unclear whether newly admitted residents also received the information or whether residents and relatives requested information sessions. It is of special concern that the authors did not mention how and when the investigators determined agreement to wear the hip protector. Frequency of hip protector use in the control group was reported at baseline only. However, during the time course of the trial a successful hip protector trial has been published , and hip protector use became a more common prevention strategy. It is possible that an increasing number of control group residents also used hip protectors.
Outcome measurement was based on routine documentation of homes and chart review by the external nurse facilitator. Numbers of falls, fallers and total fractures were not reported and probably not ascertained. It remains unclear if participants of the intervention and control centres had a similar risk of suffering a hip fracture. The reported significant difference in pelvic fractures suggests that the use of the hip protector pads was not the only important difference among the study groups.
Furthermore, the trial was limited, as seven out of 40 homes were not compliant with the introduction of the intervention and outcome ascertainment compared to six out of 87 homes not cooperating in the control group. Management of missing data has not been discussed.
Although the clustering design effect was considered in the sample size calculation, the results were not adjusted for the cluster effect.
In conclusion, critical appraisal of the study by O’Halloran revealed several major methodological flaws. It seems that hip protectors were disseminated to a heterogeneous group of elderly using an unstructured, not theory-based education and information approach. These biases affecting the internal validity of the study have not been considered by the Cochrane review. On the contrary, quality assessment by reviewers’ checklist indicated a score of 9 out of 10 .
It has been suggested previously that the assessment using a methodological criteria checklist might end up with a high score despite major mistakes . Although formal methodological criteria assessed within the Cochrane review were fulfilled, the two studies used suboptimal implementation practice and outcome collection. The inferior quality of these trials means that their findings must be questioned. The conclusion about ineffectiveness of hip protectors drawn by the Cochrane review should, therefore, be interpreted with caution.
What are the implications of our findings? They must not be misinterpreted as a pleading not to use methodological quality appraisal. Methodology of systematic reviews has developed considerably during the past years. Guidelines have been developed to improve quality of meta-analysis . However, it is not enough to rely on the author’s self-reported formal quality criteria. Reviewers should go one step further and explicitly assess the quality of the intervention not only the methodological quality. A standardised set of criteria on the quality of implementation can only inadequately assess individual, study-specific methodological flaws. We suggest a narrative expert review on quality of implementation techniques and feedback to the authors of the primary study to clarify ambiguous issues and to confirm reviewers’ judgment. Our recommendation has been forwarded to the Cochrane Collaboration.
Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P (2000) Framework for design and evaluation of complex interventions to improve health. BMJ 321:694–696
Chan DK, Hillier G, Coore M, Cooke R, Monk R, Mills J, Hung WT (2000) Effectiveness and acceptability of a newly designed hip protector: a pilot study. Arch Gerontol Geriatr 30:25–34
Ekman A, Mallmin H, Michaelsson K, Ljunghall S (1997) External hip protectors to prevent osteoporotic hip fractures. Lancet 350:563–564
Feder G, Cryer C, Donovan S, Carter Y (2000) Guidelines for the prevention of falls in people over 65. BMJ 321:1007–1011
Gillespie L, Gillespie W, Robertson M, Lamb SE, Cumming RG, Rowe BH (2003) Interventions for preventing falls in elderly people. Cochrane Database Syst Rev 4:CD000340
Herbert RD, Bo K (2005) Analysis of quality of interventions in systematic reviews. BMJ 331:507–509
Hopayian K (2001) The need for caution in interpreting high quality systematic reviews. BMJ 323:681–684
Hubacher M, Wettstein A (2001) Acceptance of hip protectors for hip fracture prevention in nursing homes. Osteoporos Int 12:794–799
Jüni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323:42–46
Kannus P, Parkkari J, Niemi S, Pasanen M, Palvanen M, Jarvinen M, Vuori I (2000) Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 343:1506–1513
Kannus P, Parkkari J, Poutala J (1999) Comparison of force attenuation properties of four different hip protectors under simulated falling conditions in the elderly: an in vitro biomechanical study. Bone 25:229–235
Keene GS, Parker MJ, Pryor GA (1993) Mortality and morbidity after hip fractures. BMJ 307:1248–1250
Koes BW, Scholten RJ, Mens JM, Bouter LM (1995) Efficacy of epidural steroid injections for low-back pain and sciatica: a systematic review of randomized clinical trials. Pain 63:279–288
Lauritzen JB, Petersen MM, Lund B (1993) Effect of external hip protectors on hip fractures. Lancet 341:11–13
Lyman GH, Kuderer NM (2005) The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol 5:14 (online)
Meyer G, Warnke A, Bender R, Mühlhauser I (2003) Effects on hip fractures of increased use of hip protectors in nursing homes: cluster randomised controlled trial. BMJ 326:376–378
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 354:1896–1900
O’Halloran PD, Cran GW, Beringer TR, Kernohan G, O’Neill C, Orr J, Dunlop L, Murray LJ (2004) A cluster randomised controlled trial to evaluate a policy of making hip protectors available to residents of nursing homes. Age Ageing 33:582–588
Parker MJ, Gillespie WJ, Gillespie LD (2006) Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ 332:571–574
Parkkari J, Kannus P, Palvanen M, Natri A, Vainio J, Aho H, Vuori I, Jarvinen M (1999) Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int 65:183–187
Piedbois P, Buyse M (2004) Meta-analyses based on abstracted data: a step in the right direction, but only a first step. J Clin Oncol 22:3839–3841
Robinovitch SN, Hayes WC, McMahon TA (1995) Energy-shunting hip padding system attenuates femoral impact force in a simulated fall. J Biomech Eng 117:409–413
Sawka AM, Boulos P, Beattie K, Thabane L, Papaioannou A, Gafni A, Cranney A, Zytaruk N, Hanley DA, Adachi JD (2005) Do hip protectors decrease the risk of hip fracture in institutional and community-dwelling elderly? A systematic review and meta-analysis of randomized controlled trials. Osteoporos Int 16:1461–1474
Van Schoor NM, Smit JH, Twisk JWR, Bouter LM, Lips P (2003) Prevention of hip fractures by external hip protectors. A randomized controlled trial. JAMA 289:1957–1962
Van Schoor NM, van der Veen AJ, Schaap LA, Smit TH, Lips P (2006) Biomechanical comparison of hard and soft hip protectors, and the influence of soft tissue. Bone 39:401–407
Warnke A, Meyer G, Bender R, Mühlhauser I (2004) Predictors of adherence to the use of hip protectors in nursing home residents. J Am Geriatr Soc 52:340–345
Wei TS, Hu CH, Wang SH, Hwang KL (2001) Fall characteristics, functional mobility and bone mineral density as risk factors of hip fracture in the community-dwelling ambulatory elderly. Osteoporos Int 12:1050–1055
About this article
Cite this article
Meyer, G., Mühlhauser, I. Hip protectors in the elderly: lack of effectiveness or just suboptimal implementation?. Eur. Rev. Aging.Phys. Act. 3, 85–90 (2006). https://doi.org/10.1007/s11556-006-0008-4